[{"Assets_0_FY_USD":11628800000.0,"EarningsPerShareBasic_1_FY_USD":0.52,"EarningsPerShareBasic_4_FY_USD":0.84,"EarningsPerShareDiluted_1_FY_USD":0.52,"EarningsPerShareDiluted_4_FY_USD":0.84,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":698900000.0,"NetIncomeLoss_1_FY_USD":73100000.0,"NetIncomeLoss_4_FY_USD":119600000.0,"StockholdersEquity_0_FY_USD":6170500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":141200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":142600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":140800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":142300000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180301"}]